Abstract

CURRENT TECHNOLOGY - CEPHEA VALVE

Sachin K. Hodgar*, Pratiksha Nikam* and Vishwal Kale

ABSTRACT

Mitral valve disease is the most common heart valve problem affecting 2.3% of the population older than 65 years. it comes in two forms regurgitation, a condition where blood leaks backward into the heart or, stenosis, narrowing of the valve new Trans catheter. Minimally invasive technologies are being developed to address mitral valve disease inpatients deemed too high a risk for conventional open-heart surgery. The mitral valve is located between the left atrium and left ventricle. Mitral valve disease occurs when the mitral valve stops working properly and results in the leakage of blood back into the left atrium. The valve can also be narrowed by stenosis, a narrowing of the valve opening There are several features of the mitral valve (saddle-shaped nonqualified annulus with irregular leaflet geometry) that make a trans catheter approach to repair or replacing the valve more challenging compared with the aortic valve. Several devices are under investigation for trans catheter mitral valve replacement are Evalve, Mitraclip and the latest technology is Cephea valve. Cephea Valve is primarily focused on the development of a less-invasive heart valve replacement technology to help treat patients suffering from mitral valve disease. The new device is being designed for patients who require replacement of diseased mitra valves in order to restore normal blood flow. It can be delivered through a vein in the leg, thereby eliminating the need for open-heart surgery. The cephea valve is mitral valve replacement device to complement its catheter-based technologies.

Keywords: Mitral Valve, Cephea Valve, Mitraclip.